CARMILA (CARM.PA) Fundamental Analysis & Valuation

EPA:CARM • FR0010828137

Current stock price

16.18 EUR
-0.08 (-0.49%)
Last:

This CARM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CARM.PA Profitability Analysis

1.1 Basic Checks

  • CARM had positive earnings in the past year.
  • CARM had a positive operating cash flow in the past year.
  • In the past 5 years CARM has always been profitable.
  • Each year in the past 5 years CARM had a positive operating cash flow.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • CARM has a Return On Assets (2.77%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 5.46%, CARM is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • CARM has a Return On Invested Capital of 3.94%. This is in the better half of the industry: CARM outperforms 66.67% of its industry peers.
  • CARM had an Average Return On Invested Capital over the past 3 years of 4.22%. This is in line with the industry average of 3.64%.
Industry RankSector Rank
ROA 2.77%
ROE 5.46%
ROIC 3.94%
ROA(3y)2.49%
ROA(5y)2.77%
ROE(3y)4.91%
ROE(5y)5.34%
ROIC(3y)4.22%
ROIC(5y)3.78%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • With a Profit Margin value of 34.10%, CARM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CARM's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 62.26%, CARM is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • CARM's Operating Margin has improved in the last couple of years.
  • CARM has a Gross Margin (74.12%) which is comparable to the rest of the industry.
  • CARM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 62.26%
PM (TTM) 34.1%
GM 74.12%
OM growth 3Y-1.31%
OM growth 5Y4.49%
PM growth 3Y-11.51%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y3.28%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100

4

2. CARM.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CARM is destroying value.
  • Compared to 1 year ago, CARM has less shares outstanding
  • Compared to 5 years ago, CARM has less shares outstanding
  • CARM has a better debt/assets ratio than last year.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.91, we must say that CARM is in the distress zone and has some risk of bankruptcy.
  • CARM has a Altman-Z score (0.91) which is in line with its industry peers.
  • The Debt to FCF ratio of CARM is 8.93, which is on the high side as it means it would take CARM, 8.93 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CARM (8.93) is better than 88.10% of its industry peers.
  • A Debt/Equity ratio of 0.75 indicates that CARM is somewhat dependend on debt financing.
  • CARM has a Debt to Equity ratio (0.75) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 8.93
Altman-Z 0.91
ROIC/WACC0.79
WACC4.97%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • CARM has a Current Ratio of 0.82. This is a bad value and indicates that CARM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.82, CARM is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
  • CARM has a Quick Ratio of 0.82. This is a bad value and indicates that CARM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 0.82, CARM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. CARM.PA Growth Analysis

3.1 Past

  • The earnings per share for CARM have decreased strongly by -40.35% in the last year.
  • CARM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.57% yearly.
  • The Revenue has been growing slightly by 7.30% in the past year.
  • The Revenue has been growing slightly by 4.84% on average over the past years.
EPS 1Y (TTM)-40.35%
EPS 3Y-4.57%
EPS 5YN/A
EPS Q2Q%-72.33%
Revenue 1Y (TTM)7.3%
Revenue growth 3Y6.86%
Revenue growth 5Y4.84%
Sales Q2Q%-1.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.65% on average over the next years.
  • CARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.68% yearly.
EPS Next Y3.43%
EPS Next 2Y3.1%
EPS Next 3Y2.65%
EPS Next 5YN/A
Revenue Next Year7.91%
Revenue Next 2Y5.66%
Revenue Next 3Y1.68%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

6

4. CARM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.26, CARM is valued correctly.
  • CARM's Price/Earnings is on the same level as the industry average.
  • CARM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.88.
  • A Price/Forward Earnings ratio of 8.53 indicates a reasonable valuation of CARM.
  • Based on the Price/Forward Earnings ratio, CARM is valued cheaper than 85.71% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CARM to the average of the S&P500 Index (22.19), we can say CARM is valued rather cheaply.
Industry RankSector Rank
PE 12.26
Fwd PE 8.53
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • 76.19% of the companies in the same industry are more expensive than CARM, based on the Enterprise Value to EBITDA ratio.
  • CARM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CARM is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.42
EV/EBITDA 14.58
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CARM does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.58
PEG (5Y)N/A
EPS Next 2Y3.1%
EPS Next 3Y2.65%

6

5. CARM.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 8.36%, CARM is a good candidate for dividend investing.
  • CARM's Dividend Yield is rather good when compared to the industry average which is at 5.52. CARM pays more dividend than 80.95% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.90, CARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.36%

5.2 History

  • On average, the dividend of CARM grows each year by 19.09%, which is quite nice.
Dividend Growth(5Y)19.09%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 95.08% of the earnings are spent on dividend by CARM. This is not a sustainable payout ratio.
  • CARM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP95.08%
EPS Next 2Y3.1%
EPS Next 3Y2.65%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARM.PA Fundamentals: All Metrics, Ratios and Statistics

CARMILA

EPA:CARM (3/27/2026, 7:00:00 PM)

16.18

-0.08 (-0.49%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)04-23
Inst Owners31.91%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap2.26B
Revenue(TTM)543.93M
Net Income(TTM)185.47M
Analysts81.43
Price Target20.55 (27.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 8.36%
Yearly Dividend1.26
Dividend Growth(5Y)19.09%
DP95.08%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.14%
PT rev (3m)-2.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.39%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.35%
Revenue NY rev (3m)5.25%
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 8.53
P/S 4.15
P/FCF 7.42
P/OCF 7.21
P/B 0.67
P/tB 0.67
EV/EBITDA 14.58
EPS(TTM)1.32
EY8.16%
EPS(NY)1.9
Fwd EY11.73%
FCF(TTM)2.18
FCFY13.48%
OCF(TTM)2.24
OCFY13.87%
SpS3.9
BVpS24.31
TBVpS24.3
PEG (NY)3.58
PEG (5Y)N/A
Graham Number26.87
Profitability
Industry RankSector Rank
ROA 2.77%
ROE 5.46%
ROCE 5.36%
ROIC 3.94%
ROICexc 3.96%
ROICexgc 3.96%
OM 62.26%
PM (TTM) 34.1%
GM 74.12%
FCFM 55.99%
ROA(3y)2.49%
ROA(5y)2.77%
ROE(3y)4.91%
ROE(5y)5.34%
ROIC(3y)4.22%
ROIC(5y)3.78%
ROICexc(3y)4.48%
ROICexc(5y)4.01%
ROICexgc(3y)4.48%
ROICexgc(5y)4.01%
ROCE(3y)5.74%
ROCE(5y)5.15%
ROICexgc growth 3Y3.82%
ROICexgc growth 5Y7.41%
ROICexc growth 3Y3.83%
ROICexc growth 5Y7.42%
OM growth 3Y-1.31%
OM growth 5Y4.49%
PM growth 3Y-11.51%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y3.28%
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 8.93
Debt/EBITDA 7.52
Cap/Depr 703.33%
Cap/Sales 1.63%
Interest Coverage 3.72
Cash Conversion 92.2%
Profit Quality 164.2%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 0.91
F-Score7
WACC4.97%
ROIC/WACC0.79
Cap/Depr(3y)292.77%
Cap/Depr(5y)236.94%
Cap/Sales(3y)1.16%
Cap/Sales(5y)1.43%
Profit Quality(3y)3329.79%
Profit Quality(5y)2052.62%
High Growth Momentum
Growth
EPS 1Y (TTM)-40.35%
EPS 3Y-4.57%
EPS 5YN/A
EPS Q2Q%-72.33%
EPS Next Y3.43%
EPS Next 2Y3.1%
EPS Next 3Y2.65%
EPS Next 5YN/A
Revenue 1Y (TTM)7.3%
Revenue growth 3Y6.86%
Revenue growth 5Y4.84%
Sales Q2Q%-1.58%
Revenue Next Year7.91%
Revenue Next 2Y5.66%
Revenue Next 3Y1.68%
Revenue Next 5YN/A
EBIT growth 1Y-25.54%
EBIT growth 3Y5.46%
EBIT growth 5Y9.55%
EBIT Next Year-0.07%
EBIT Next 3Y1.08%
EBIT Next 5Y1.22%
FCF growth 1Y3.85%
FCF growth 3Y-0.21%
FCF growth 5Y12.75%
OCF growth 1Y5.78%
OCF growth 3Y-0.93%
OCF growth 5Y13.27%

CARMILA / CARM.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CARMILA?

ChartMill assigns a fundamental rating of 5 / 10 to CARM.PA.


What is the valuation status of CARMILA (CARM.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to CARMILA (CARM.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for CARMILA?

CARMILA (CARM.PA) has a profitability rating of 5 / 10.


How financially healthy is CARMILA?

The financial health rating of CARMILA (CARM.PA) is 4 / 10.


Can you provide the dividend sustainability for CARM stock?

The dividend rating of CARMILA (CARM.PA) is 6 / 10 and the dividend payout ratio is 95.08%.